[Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
D003920:Diabetes Mellitus / Q000628:therapy*; D007004:Hypoglycemic Agents; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D000077145:Sulfanilamide; D014508:Urea
DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; UREA/related compounds
Uber die Wirkung des peroralen Antidiabetikums N1-Sulfanilyl-N2-n-butyl-carbamid (Nadisan, Invenol) auf den menschlichen Diabetes mellitus.